Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 0487-0201

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 0487-0201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nephron Pharmaceuticals Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5387e98-figure-01 (B5387e98 Figure 01)

FDA Label Image

B5387e98-figure-02 (B5387e98 Figure 02)

FDA Label Image

B5387e98-figure-03 (B5387e98 Figure 03)

The text appears to be a list of numbers, symbols, and a medication name "Albuterol + Ipratropium" with the corresponding medication type "mimutoral Sulfote Inhalation Solution". It is likely a prescription label or package insert.*

FDA Label Image

B5387e98-figure-04 (B5387e98 Figure 04)

This is a report on adverse events occurring in patients taking different treatments for respiratory and urogenital issues. The report shows data for three groups of patients taking two different types of medications (Albuterol and Ipratropium) and a combination of the two. The table lists the percentage of patients experiencing adverse events such as pain, chest pain, diarrhea, dyspepsia, nausea, leg cramps, bronchitis, lung disease, pharyngitis, pneumonia, and urinary tract infection.*

FDA Label Image

B5387e98-figure-05 (B5387e98 Figure 05)

FDA Label Image

B5387e98-figure-06 (B5387e98 Figure 06)

FDA Label Image

B5387e98-figure-07 (B5387e98 Figure 07)

FDA Label Image

B5387e98-figure-08 (B5387e98 Figure 08)

FDA Label Image

B5387e98-figure-09 (B5387e98 Figure 09)

Ipratropium Bromide and Albuterol Sulfate is a medication prescribed for oral inhalation only. Each vial contains 0.5 mg Ipratropium bromide and 3 mg Albuterol sulfate equivalent to 2.5 mg Albuterol base. It comes in a unit-dose vial and should be stored between 2 and 25°C. The solution should be colorless, otherwise, discard it. This medication should be used only under a physician's direction, and contact them if you have additional questions.*

FDA Label Image

B5387e98-figure-10 (B5387e98 Figure 10)

This is a description of a medication with the NDC code 0467-0201-03. It contains Ipratropium Bromide 0.5'mg + and Albuterol Sulfate 3mg. It is for oral inhalation use only. The rest of the text is not legible.*

FDA Label Image

B5387e98 Figure 11

This appears to be a description of a medication meant for oral inhalation with the brand name "Bneohron". The medication contains Ipratropium Bromide and Albuterol Sulfate, and the dosage is 0.5mg and 3mg respectively. The NDC code for this product is 0487020150. The rest of the text appears to be gibberish or unclear due to errors.*

FDA Label Image

B5387e98 Figure 12

This text provides patient instructions for using a medication called Ipratropium Bromide and Albuterol Sulfate for oral inhalation. The instructions include steps to follow when taking the medication using a nebulizer, as well as information on storage conditions and dosage. Patients are advised to read the information carefully every time their prescription is filled as information may have changed. The text also includes the manufacturer's information and contact details for customer service.*

FDA Label Image

B5387e98 Figure 13

FDA Label Image

B5387e98 Figure 14

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.